Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDYield10 Bioscience, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$6.24 | -$6.24 | -$6.24 |
| Q2 2025 | 1 | -$6.24 | -$6.24 | -$6.24 |
| Q3 2025 | 1 | -$4.32 | -$4.32 | -$4.32 |
| Q4 2025 | 1 | -$5.04 | -$5.04 | -$5.04 |
Yield10 Bioscience, Inc. Earnings Date And Information
Yield10 Bioscience, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-5.04 earnings per share for the quarter, missing analysts' consensus estimates of $-3.96 by $1.08. The company had revenue of 450,000 for the quarter and had revenue of 60,000 for the year. Yield10 Bioscience, Inc. has generated $-44 earnings per share over the last year ($-43.66 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Yield10 Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 16th, 2024 based on prior year's report dates.
Yield10 Bioscience, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$3.96 | -$5.04 | -1.08 | $375,000 | $450,000 |
| 05/15/2024 | Q1 2024 | N/A | -$4.77 | N/A | N/A | $300,000 |
| 04/01/2024 | Q4 2023 | -$2.64 | -$6.54 | -3.9 | N/A | $60,000 |
| 11/14/2023 | Q3 2023 | -$7.43 | -$9.95 | -2.52 | $75,000 | $0 |
| 08/14/2023 | Q2 2023 | -$11.51 | -$15.42 | -3.91 | $33,333 | $0 |
| 05/12/2023 | Q1 2023 | N/A | -$18.07 | N/A | N/A | $60,000 |
| 03/14/2023 | Q4 2022 | $0.60 | -$16.03 | -16.63 | N/A | $87,000 |
| 11/14/2022 | Q3 2022 | -$16.79 | -$17.00 | -0.21 | $124,667 | $111,000 |
| 08/10/2022 | Q2 2022 | -$16.55 | -$16.86 | -0.31 | $159,250 | $103,000 |
| 05/11/2022 | Q1 2022 | -$15.83 | -$16.35 | -0.52 | N/A | $149,000 |
| 03/25/2022 | Q4 2021 | N/A | -$14.65 | N/A | N/A | $152,000 |
| 11/10/2021 | Q3 2021 | -$15.11 | -$11.81 | 3.3 | $207,000 | $92,000 |
| 08/11/2021 | Q2 2021 | -$12.71 | -$15.24 | -2.53 | $192,500 | $174,000 |
| 05/11/2021 | Q1 2021 | -$11.03 | -$14.31 | -3.28 | N/A | $196,000 |
| 03/16/2021 | Q4 2020 | -$0.70 | -$19.02 | -18.32 | N/A | $195,000 |
| 11/12/2020 | Q3 2020 | -$19.42 | -$20.88 | -1.46 | $229,500 | $204,000 |
| 08/11/2020 | Q2 2020 | -$1.30 | -$22.02 | -20.72 | $182,333 | $221,000 |
| 05/14/2020 | Q1 2020 | N/A | -$50.91 | N/A | N/A | $179,000 |
| 03/24/2020 | Q4 2019 | N/A | -$288.53 | N/A | N/A | $140,000 |
| 11/12/2019 | Q3 2019 | -$6.60 | -$151.99 | -145.39 | $162,500 | $224,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Yield10 Bioscience, Inc. Earnings: FAQ's
Yield10 Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 16th, 2024 based offlast year's report dates.
The conference call for Yield10 Bioscience, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Yield10 Bioscience, Inc.'s latest earnings report can be read online.
Yield10 Bioscience, Inc. (:YTEN) has a recorded annual revenue of $60,000.
Yield10 Bioscience, Inc. (:YTEN) has a recorded net income of $-14,455,000.Yield10 Bioscience, Inc. has generated $-43.66 earnings per share over the last four quarters.
Yield10 Bioscience, Inc. (:YTEN) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.